Trexquant Investment’s BeOne Medicines Ltd ONC Stock Holding History

Trexquant Investment’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.89M	Buy	20,683 +16,646	+412%	+$4.91M	0.03%	665
2026 Q1	$1.2M	Sell	4,037 -1,218	-23%	-$394K	0.01%	1170
2025 Q4	$1.6M	Buy	+5,255	New	+$1.72M	0.01%	1062
2025 Q3	–	Sell	-21,049	Closed	-$5.1M	–	1984
2025 Q2	$5.1M	Buy	+21,049	New	+$5.16M	0.06%	520
2024 Q1	–	Sell	-6,090	Closed	-$1.1M	–	1840
2023 Q4	$1.1M	Buy	+6,090	New	+$1.1M	0.02%	791
2023 Q2	–	Sell	-1,736	Closed	-$374K	–	1874
2023 Q1	$374K	Buy	+1,736	New	+$416K	0.01%	1111
2022 Q3	–	Sell	-1,682	Closed	-$272K	–	1906
2022 Q2	$272K	Buy	+1,682	New	+$263K	0.01%	1178
2021 Q3	–	Sell	-2,033	Closed	-$698K	–	1555
2021 Q2	$698K	Buy	+2,033	New	+$673K	0.06%	391
2020 Q2	–	Sell	-3,050	Closed	-$375K	–	1549
2020 Q1	$375K	Buy	+3,050	New	+$477K	0.03%	768
2019 Q3	–	Sell	-9,248	Closed	-$1.15M	–	1149
2019 Q2	$1.15M	Buy	9,248 +4,577	+98%	+$581K	0.1%	286
2019 Q1	$617K	Buy	+4,671	New	+$630K	0.04%	524

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Trexquant Investment's ONC Position: Q2 2026 in Review

Trexquant Investment increased its BeOne Medicines Ltd (ONC) stake by 412% in Q2 2026, buying an estimated $4.91M and bringing the position to 20,683 shares worth $5.89M. The position accounts for 0.03% of the portfolio, ranked #665.

Trexquant Investment first reported a position in ONC in Q1 2019 and has held it in 11 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Trexquant Investment held 20,683 shares of BeOne Medicines Ltd worth $5.89M as of Q2 2026.
Trexquant Investment bought 16,646 BeOne Medicines Ltd shares in Q2 2026, an estimated $4.91M.
BeOne Medicines Ltd made up 0.03% of Trexquant Investment's portfolio in Q2 2026, its #665 holding.
Trexquant Investment first reported a position in BeOne Medicines Ltd in Q1 2019 and has held it in 11 quarters since.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.